Abdominal Wall Surgery: Redefining Expertise for an Emerging Specialty
Columbia Hernia Center surgeons present factors that are changing the surgical landscape for hernia repair from open operations to minimally invasive approaches.
Benefits of Colonic Stents as a Bridge to Surgery
Weill Cornell Medicine surgical oncologist and colon and rectal surgeon, Dr. Heather Yeo, and her team conduct the first study to use propensity score matching comparing colonic stenting with immediate resection.
Familial Pancreatic Cancer: Confronting the Risk
Columbia gastroenterologists discuss hereditary cancer syndromes associated with pancreatic cancer and approaches to identify risk.
Bacteria Underlie Success of Fecal Microbiota Transplants for Ulcerative Colitis
Weill Cornell Medicine gastroenterology faculty identify the transfer of bacterial strains that correlate with treatment effectiveness of fecal microbiota transplantation for ulcerative colitis.
Establishing Practice Guidelines for Endoscopic Evaluation of Altered Bowel Anatomy
Experts in inflammatory bowel disease from around the world convene for a consensus consortium led by Dr. Bo Shen at Columbia University to develop guidelines for endoscopy following surgery.
Making Headway in Treatment for Esophageal Cancer
Columbia University and Weill Cornell Medicine gastroenterology clinician-scientists publish seminal research on targeted and combination therapies that have the potential to extend survival for patients with advanced esophageal cancer.
Lynch Syndrome: Reducing the Risk of Cancer with Genetic Precision
Comprehensive GI Clinical Cancer Genetics programs at NewYork-Presbyterian Hospital are furthering the understanding of inherited cancer syndromes, including Lynch syndrome, and methods to improve early screening, including genetic testing, to prevent the development of cancer.
Gastroenterology & Oncology
Novel Perspectives on Pancreatic Cancer
Comprehensive medical and surgical oncology programs for pancreatic cancer at NYP complement exhaustive research underway by Columbia and Weill Cornell faculty in the basic, translational, and clinical arenas. Their goal is to identify new treatment approaches that defy the odds for surviving this devastating disease.
Page1 of 3